Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""drug users"" wg kryterium: Temat


Tytuł:
Clinical characteristics of over-the-counter (OTC) drug abusers in psychiatric practice in Japan: Comparison of single and multiple OTC product abusers.
Autorzy:
Tanibuchi Y; Chiba Hospital, Funabashi, Japan.; Department of Drug Dependence Research, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, Japan.
Omiya S; Department of Drug Dependence Research, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, Japan.; Clinical Psychology, Graduate School of Education, Joetsu University of Education, Joetsu, Japan.
Usami T; Department of Drug Dependence Research, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, Japan.; Kitakyushu Municipal Mental Health Welfare Center, Kitakyushu, Japan.
Matsumoto T; Department of Drug Dependence Research, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, Japan.
Pokaż więcej
Źródło:
Neuropsychopharmacology reports [Neuropsychopharmacol Rep] 2024 Mar; Vol. 44 (1), pp. 176-186. Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Users*
Adult ; Humans ; Female ; Japan ; Nonprescription Drugs/adverse effects ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł:
How do people who use opioids express their qualities and capacities? An assessment of attitudes, behaviors, and opportunities.
Autorzy:
Ezell JM; Community Health Sciences, Berkeley Center for Cultural Humility, School of Public Health, University of California Berkeley, Berkeley, CA, USA. .; Berkeley Center for Cultural Humility, University of California Berkeley, Berkeley, CA, USA. .
Pho MT; Department of Medicine, Section of Infectious Diseases and Global Health, University of Chicago Medicine, Chicago, IL, USA.
Simek E; Community Health Sciences, Berkeley Center for Cultural Humility, School of Public Health, University of California Berkeley, Berkeley, CA, USA.; Berkeley Center for Cultural Humility, University of California Berkeley, Berkeley, CA, USA.
Ajayi BP; Biology and Society, Cornell University, Ithaca, NY, USA.
Shetty N; Biology and Society, Cornell University, Ithaca, NY, USA.
Walters SM; Department of Population Health at NYU Grossman School of Medicine, New York, NY, USA.
Pokaż więcej
Źródło:
Harm reduction journal [Harm Reduct J] 2024 Apr 08; Vol. 21 (1), pp. 79. Date of Electronic Publication: 2024 Apr 08.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Users*
Substance-Related Disorders*/epidemiology
Humans ; Analgesics, Opioid/therapeutic use ; Attitude ; Harm Reduction
Czasopismo naukowe
Tytuł:
Opportunities for cancer prevention at syringe services programs: acceptability of HPV self-sampling and vaccination among people who inject drugs.
Autorzy:
Hinkes S; Department of Medical Education, University of Miami Miller School of Medicine, Miami, FL, USA. .; Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA. .
Ciraldo K; Department of Obstetrics & Gynecology, University of Miami Miller School of Medicine, Miami, FL, USA.
Kobetz E; Division of Medical Oncology, Department of Medicine and Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Bartholomew TS; Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Rinehart S; Department of Medical Education, University of Miami Miller School of Medicine, Miami, FL, USA.
Siringo N; Department of Medical Education, University of Miami Miller School of Medicine, Miami, FL, USA.
Barnett R; Department of Medical Education, University of Miami Miller School of Medicine, Miami, FL, USA.
Godbole N; Department of Medical Education, University of Miami Miller School of Medicine, Miami, FL, USA.
Jeanty F; Department of Medical Education, University of Miami Miller School of Medicine, Miami, FL, USA.
Frederick M; Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
Tookes HE; Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
Pokaż więcej
Źródło:
Harm reduction journal [Harm Reduct J] 2024 Mar 27; Vol. 21 (1), pp. 70. Date of Electronic Publication: 2024 Mar 27.
Typ publikacji:
Journal Article
MeSH Terms:
Substance Abuse, Intravenous*
Drug Users*
Papillomavirus Infections*/prevention & control
Papillomavirus Infections*/diagnosis
Uterine Cervical Neoplasms*/prevention & control
Uterine Cervical Neoplasms*/diagnosis
Female ; Humans ; Vaccination ; Patient Acceptance of Health Care
Czasopismo naukowe
Tytuł:
Acceptance and feasibility of a low-threshold and substitution services-based periodical monitoring system for blood-borne and sexually transmitted infections among people who inject drugs in Germany: a mixed-methods analysis.
Autorzy:
Krings A; Department of Infectious Disease Epidemiology, Robert Koch Institute, Nordufer 20, 13353, Berlin, Germany. .
Steffen G; Department of Infectious Disease Epidemiology, Robert Koch Institute, Nordufer 20, 13353, Berlin, Germany.
Zimmermann R; Department of Infectious Disease Epidemiology, Robert Koch Institute, Nordufer 20, 13353, Berlin, Germany.
Pokaż więcej
Corporate Authors:
DRUCK 2.0-study group
Źródło:
Harm reduction journal [Harm Reduct J] 2024 Mar 14; Vol. 21 (1), pp. 62. Date of Electronic Publication: 2024 Mar 14.
Typ publikacji:
Journal Article
MeSH Terms:
Substance Abuse, Intravenous*/drug therapy
Drug Users*
Sexually Transmitted Diseases*
HIV Infections*/prevention & control
Hepatitis C*/epidemiology
Humans ; Feasibility Studies ; Pilot Projects
Czasopismo naukowe
Tytuł:
The burden of skin and soft tissue, bone and joint infections in an Australian cohort of people who inject drugs.
Autorzy:
Morgan B; Department of Medicine, Monash Health, Clayton, Australia. .
Lancaster R; Addiction Medicine Unit, Monash Health, Clayton, Australia.
Boyagoda B; Central Clinical School, Monash University, Clayton, Australia.
Ananda R; Department of Medicine, Monash Health, Clayton, Australia.
Attwood LO; Central Clinical School, Monash University, Clayton, Australia.; Department of Infectious Diseases, Alfred Health, Clayton, Australia.; Monash Infectious Diseases, Monash Health, Clayton, Australia.
Jacka D; Addiction Medicine Unit, Monash Health, Clayton, Australia.
Woolley I; Central Clinical School, Monash University, Clayton, Australia. .; Department of Infectious Diseases, Alfred Health, Clayton, Australia. .; Monash Infectious Diseases, Monash Health, Clayton, Australia. .; School of Clinical Sciences, Monash University, Clayton, Australia. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Mar 07; Vol. 24 (1), pp. 299. Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:
Journal Article
MeSH Terms:
Substance Abuse, Intravenous*/complications
Drug Users*
Hepatitis C*
Soft Tissue Infections*/epidemiology
Arthritis, Infectious*
Adult ; Humans ; Male ; Female ; Retrospective Studies ; Bone and Bones ; Victoria
Czasopismo naukowe
Tytuł:
Integration of Hepatitis C and Addiction Treatment in People Who Inject Drugs: The San Patrignano HCV-Free and Drug-Free Experience.
Autorzy:
Piselli P; Clinical Epidemiology Unit, Department of Epidemiology and Preclinical Research, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy.
Boschini A; Medical Center, Comunità di S. Patrignano, 47853 Coriano, RN, Italy.
Gianfreda R; Infectious Disease Unit, Hospital of Rimini 'Gli Infermi', 47923 Rimini, Italy.
Nappo A; Clinical Epidemiology Unit, Department of Epidemiology and Preclinical Research, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy.
Cimaglia C; Clinical Epidemiology Unit, Department of Epidemiology and Preclinical Research, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy.
Scarfò G; Clinical Epidemiology Unit, Department of Epidemiology and Preclinical Research, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy.
Smacchia C; Medical Center, Comunità di S. Patrignano, 47853 Coriano, RN, Italy.
Paoletti R; Medical Center, Comunità di S. Patrignano, 47853 Coriano, RN, Italy.
Duehren S; Medical Center, Comunità di S. Patrignano, 47853 Coriano, RN, Italy.
Girardi E; Clinical Epidemiology Unit, Department of Epidemiology and Preclinical Research, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy.
Pokaż więcej
Źródło:
Viruses [Viruses] 2024 Feb 28; Vol. 16 (3). Date of Electronic Publication: 2024 Feb 28.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Users*
Hepatitis C, Chronic*/drug therapy
Substance Abuse, Intravenous*/complications
Hepatitis C*/diagnosis
Hepatitis C*/drug therapy
Humans ; Hepacivirus/genetics ; Antiviral Agents/therapeutic use ; Reinfection ; RNA
Czasopismo naukowe
Tytuł:
Structural stigma within inpatient care for people who inject drugs: implications for harm reduction.
Autorzy:
Rehman M; Department of Psychiatry, Schulich School of Medicine and Dentistry, Western University, London, Canada.; Institute of Living Terry Building, Institute of LivingHartford Hospital, 200 Retreat Avenue, Hartford, CT, 06106, USA.
Chapman L; Inner City Health Associates, Toronto, Canada.
Liu L; Department of Psychiatry, Schulich School of Medicine and Dentistry, Western University, London, Canada.
Calvert S; Department of Psychiatry, Schulich School of Medicine and Dentistry, Western University, London, Canada.; Northern Ontario School of Medicine, Sudbury, ON, Canada.
Sukhera J; Department of Psychiatry, Schulich School of Medicine and Dentistry, Western University, London, Canada. .; Institute of Living Terry Building, Institute of LivingHartford Hospital, 200 Retreat Avenue, Hartford, CT, 06106, USA. .
Pokaż więcej
Źródło:
Harm reduction journal [Harm Reduct J] 2024 Feb 27; Vol. 21 (1), pp. 53. Date of Electronic Publication: 2024 Feb 27.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Users*
Substance-Related Disorders*/therapy
Humans ; Pharmaceutical Preparations ; Harm Reduction ; Inpatients ; Social Stigma
Czasopismo naukowe
Tytuł:
Improving access to HIV care among people who inject drugs through tele-harm reduction: a qualitative analysis of perceived discrimination and stigma.
Autorzy:
Scaramutti C; Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA. .
Hervera B; Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Rivera Y; Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Chueng TA; 2Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
Forrest DW; Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Suarez E Jr; Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Serota DP; 2Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
Alkamli H; Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Ciraldo K; Department of Family and Community Medicine & Department of Obstetrics, Gynecology and Reproductive Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Bartholomew TS; Division of Health Services Research and Policy, Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Tookes HE; 2Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
Pokaż więcej
Źródło:
Harm reduction journal [Harm Reduct J] 2024 Feb 23; Vol. 21 (1), pp. 50. Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:
Journal Article
MeSH Terms:
Substance Abuse, Intravenous*/complications
Substance Abuse, Intravenous*/therapy
Drug Users*
HIV Infections*/complications
HIV Infections*/therapy
Humans ; Health Services Accessibility ; Harm Reduction ; Perceived Discrimination
Czasopismo naukowe
Tytuł:
Overreporting of adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs in the HERO study.
Autorzy:
Lopes SS; Department of Public Health Sciences, Clemson University, 29634, Clemson, SC, USA.
Pericot-Valverde I; Department of Psychology, College of Behavioral, Social, and Health Sciences, Clemson University, 29634, Clemson, SC, USA.
Lum PJ; Department of Medicine, University of California, San Francisco, 1001 Potrero Ave, 94110, San Francisco, CA, USA.
Taylor LE; Department of Pharmacy Practice and Clinical Research, University of Rhode Island, 7 Greenhouse Road, 02881, Kingston, RI, USA.
Mehta SH; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, Room E6546, 21205, Baltimore, MD, USA.
Tsui JI; Department of Medicine, University of Washington, 325 9th Ave, 98104, Seattle, WA, USA.
Feinberg J; Department of Behavioral Medicine and Psychiatry, West Virginia University School of Medicine, 930 Chestnut Ridge Road, 26505, Morgantown, WV, USA.; Department of Medicine, Section of Infectious Diseases, West Virginia University School of Medicine, 1 Medical Center Drive, 26506, Morgantown, WV, USA.
Kim AY; Division of Infectious Diseases, Massachusetts General Hospital, 55 Fruit St, 02114, Boston, MA, USA.; Harvard Medical School, 02115, Boston, MA, USA.
Norton BL; Albert Einstein College of Medicine, 10461, Bronx, NY, USA.; Department of Medicine, Montefiore Medical Center, 10467, Bronx, NY, USA.
Page K; Department of Internal Medicine, Health Sciences Center, University of New Mexico, University of New Mexico, MSC 10, 5550, 87131, Albuquerque, NM, USA.
Murray-Krezan C; Division of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine, 15213, Pittsburgh, PA, USA.
Anderson J; Department of Internal Medicine, Health Sciences Center, University of New Mexico, University of New Mexico, MSC 10, 5550, 87131, Albuquerque, NM, USA.
Karasz A; UMass Chan Medical School, University of Massachusetts Medical School, 55 Lake Ave, North, 01605, Worcester, MA, USA.
Arnsten J; Albert Einstein College of Medicine, 10461, Bronx, NY, USA.; Department of Medicine, Montefiore Medical Center, 10467, Bronx, NY, USA.
Moschella P; Department of Emergency Medicine, Prisma Health, Greenville, SC, USA.; School of Health Research, Clemson University, Clemson, SC, USA.; Department of Medicine, University of South Carolina School of Medicine, 876 W Faris Rd, 29605, Greenville, SC, USA.
Heo M; Department of Public Health Sciences, Clemson University, 29634, Clemson, SC, USA.
Litwin AH; School of Health Research, Clemson University, Clemson, SC, USA. .; Department of Medicine, University of South Carolina School of Medicine, 876 W Faris Rd, 29605, Greenville, SC, USA. .; Department of Medicine, Prisma Health, 29605, Greenville, SC, USA. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Feb 23; Vol. 24 (1), pp. 251. Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Users*
Substance Abuse, Intravenous*/complications
Substance Abuse, Intravenous*/drug therapy
Hepatitis C, Chronic*/drug therapy
Hepatitis C*/drug therapy
Hepatitis C*/complications
Humans ; Antiviral Agents/therapeutic use ; Hepacivirus/genetics ; Sustained Virologic Response
Czasopismo naukowe
Tytuł:
Loneliness and fearfulness are associated with non-fatal drug overdose among people who inject drugs.
Autorzy:
Falade-Nwulia O; Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
Ward K; Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.; School of Public Health, Drexel University, Philadelphia, PA, United States of America.
Wagner KD; School of Public Health, University of Nevada, Reno, NV, United States of America.
Karimi-Sari H; Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
Hsu J; Department of Psychiatry and Behavioral Science, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
Sulkowski M; Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
Latkin C; Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
Nwulia E; Department of Psychiatry, Howard University, Washington, DC, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Feb 21; Vol. 19 (2), pp. e0297209. Date of Electronic Publication: 2024 Feb 21 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Substance Abuse, Intravenous*/complications
Drug Users*
Drug Overdose*/epidemiology
Drug Overdose*/psychology
Humans ; Female ; Adult ; Middle Aged ; Male ; Loneliness ; Cross-Sectional Studies
Czasopismo naukowe
Tytuł:
Delivering integrated strategies from a mobile unit to address the intertwining epidemics of HIV and addiction in people who inject drugs: the HPTN 094 randomized controlled trial protocol (the INTEGRA Study).
Autorzy:
Goodman-Meza D; Division of Infectious Diseases, David Geffen School of Medicine, University of California, Los Angeles, 10833 Le Conte Ave., CHS 52-215, Los Angeles, CA, 90095-1688, USA. .
Shoptaw S; Department of Family Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
Hanscom B; Statistical Center for HIV/AIDS Research and Prevention (SCHARP), Seattle, WA, USA.
Smith LR; Division of Infectious Diseases and Global Public Health, University of California, San Diego, San Diego, CA, USA.
Andrew P; Family Health International (FHI 360), Durham, NC, USA.
Kuo I; Milken Institute School of Public Health Department of Epidemiology, George Washington University, Washington, DC, USA.
Lake JE; UTHealth-Houston, Houston, TX, USA.
Metzger D; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Morrison EAB; ICAP, Mailman School of Public Health, Columbia University, New York, NY, USA.
Cummings M; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Fogel JM; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Richardson P; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Harris J; Family Health International (FHI 360), Durham, NC, USA.
Heitner J; Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA.
Stansfield S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
El-Bassel N; School of Social Work, Columbia University, New York, NY, USA.
Pokaż więcej
Corporate Authors:
HPTN 094 Study Team
Źródło:
Trials [Trials] 2024 Feb 15; Vol. 25 (1), pp. 124. Date of Electronic Publication: 2024 Feb 15.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Substance Abuse, Intravenous*/epidemiology
Substance Abuse, Intravenous*/complications
Drug Users*
HIV Infections*/diagnosis
HIV Infections*/epidemiology
HIV Infections*/prevention & control
Sexually Transmitted Diseases*/diagnosis
Sexually Transmitted Diseases*/epidemiology
Sexually Transmitted Diseases*/prevention & control
Opioid-Related Disorders*/diagnosis
Opioid-Related Disorders*/epidemiology
Opioid-Related Disorders*/prevention & control
Humans ; Pharmaceutical Preparations ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł:
Reported xylazine exposure highly associated with overdose outcomes in a rapid community assessment among people who inject drugs in Baltimore.
Autorzy:
German D; Department of Health, Behavior, and Society, Bloomberg School of Public Health, Johns Hopkins University, 624 N. Broadway, Baltimore, MD, 21205, USA. .
Genberg B; Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
Sugarman O; Department of Health, Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
Saloner B; Department of Health, Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
Sawyer A; Department of Health, Behavior, and Society, Bloomberg School of Public Health, Johns Hopkins University, 624 N. Broadway, Baltimore, MD, 21205, USA.
Glick JL; Department of Health, Behavior, and Society, Bloomberg School of Public Health, Johns Hopkins University, 624 N. Broadway, Baltimore, MD, 21205, USA.
Gribbin M; Maryland Department of Health, Baltimore, MD, USA.
Flynn C; Maryland Department of Health, Baltimore, MD, USA.
Pokaż więcej
Źródło:
Harm reduction journal [Harm Reduct J] 2024 Jan 22; Vol. 21 (1), pp. 18. Date of Electronic Publication: 2024 Jan 22.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Users*
Drug Overdose*
Humans ; Xylazine ; Baltimore/epidemiology ; Fentanyl
Czasopismo naukowe
Tytuł:
Does a simplified algorithm and integrated HCV care model improve linkage to care, retention, and cure among people who inject drugs? A pragmatic quality improvement randomized controlled trial protocol.
Autorzy:
Klaman SL; Laura Rodriguez Research Institute - Family Health Centers of San Diego, 1750 Fifth Avenue, San Deigo, CA, 92101, USA.
Godino JG; Laura Rodriguez Research Institute - Family Health Centers of San Diego, 1750 Fifth Avenue, San Deigo, CA, 92101, USA. .
Northrup A; Laura Rodriguez Research Institute - Family Health Centers of San Diego, 1750 Fifth Avenue, San Deigo, CA, 92101, USA.
Lewis SV; Laura Rodriguez Research Institute - Family Health Centers of San Diego, 1750 Fifth Avenue, San Deigo, CA, 92101, USA.
Tam A; Laura Rodriguez Research Institute - Family Health Centers of San Diego, 1750 Fifth Avenue, San Deigo, CA, 92101, USA.
Carrillo C; Laura Rodriguez Research Institute - Family Health Centers of San Diego, 1750 Fifth Avenue, San Deigo, CA, 92101, USA.
Lewis R; Laura Rodriguez Research Institute - Family Health Centers of San Diego, 1750 Fifth Avenue, San Deigo, CA, 92101, USA.
Matthews E; Laura Rodriguez Research Institute - Family Health Centers of San Diego, 1750 Fifth Avenue, San Deigo, CA, 92101, USA.
Mendez B; Laura Rodriguez Research Institute - Family Health Centers of San Diego, 1750 Fifth Avenue, San Deigo, CA, 92101, USA.
Reyes L; Laura Rodriguez Research Institute - Family Health Centers of San Diego, 1750 Fifth Avenue, San Deigo, CA, 92101, USA.
Rojas S; Laura Rodriguez Research Institute - Family Health Centers of San Diego, 1750 Fifth Avenue, San Deigo, CA, 92101, USA.
Ramers C; Laura Rodriguez Research Institute - Family Health Centers of San Diego, 1750 Fifth Avenue, San Deigo, CA, 92101, USA.
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Jan 19; Vol. 24 (1), pp. 105. Date of Electronic Publication: 2024 Jan 19.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Hepatitis C, Chronic*/drug therapy
Hepatitis C, Chronic*/epidemiology
Substance Abuse, Intravenous*/complications
Substance Abuse, Intravenous*/drug therapy
Drug Users*
Hepatitis C*/drug therapy
Hepatitis C*/epidemiology
Adult ; Humans ; Hepacivirus ; Antiviral Agents/therapeutic use ; Prospective Studies ; Quality Improvement ; Seroepidemiologic Studies ; Algorithms ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł:
Prevention of Viral Hepatitis and HIV Infection among People Who Inject Drugs: A Systematic Review and Meta-Analysis.
Autorzy:
Chen YJ; Research Assistant Center, Tainan Municipal Hospital (Managed by Show Chwan Medical Care Corporation), Tainan 701033, Taiwan.; Department of Food Nutrition, Chung Hwa University of Medical Technology, Tainan 717302, Taiwan.
Lin YC; Research Assistant Center, Tainan Municipal Hospital (Managed by Show Chwan Medical Care Corporation), Tainan 701033, Taiwan.
Wu MT; Research Assistant Center, Tainan Municipal Hospital (Managed by Show Chwan Medical Care Corporation), Tainan 701033, Taiwan.
Kuo JY; Department of Hepatogastroenterology, Tainan Municipal Hospital (Managed by Show Chwan Medical Care Corporation), Tainan 701033, Taiwan.
Wang CH; Department of Hepatogastroenterology, Tainan Municipal Hospital (Managed by Show Chwan Medical Care Corporation), Tainan 701033, Taiwan.
Pokaż więcej
Źródło:
Viruses [Viruses] 2024 Jan 18; Vol. 16 (1). Date of Electronic Publication: 2024 Jan 18.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:
HIV Infections*/drug therapy
HIV Infections*/prevention & control
Drug Users*
Coinfection*/prevention & control
Hepatitis, Viral, Human*
Humans ; Databases, Factual
Czasopismo naukowe
Tytuł:
People Who Inject Drugs in Mozambique: We need to normalize HIV treatment and care services in specialized community centers for people who inject drugs!
Autorzy:
Semá Baltazar C; National Institute of Health, P.O. Box 264, Maputo, Mozambique. .
Ribeiro Banze A; National Institute of Health, P.O. Box 264, Maputo, Mozambique.
Seleme J; Mozambique National Program for STI, HIV and AIDS Control, Ministry Oh Health, Maputo, Mozambique.
Boothe M; UNAIDS, Maputo, Mozambique.
Pokaż więcej
Źródło:
Harm reduction journal [Harm Reduct J] 2024 Jan 06; Vol. 21 (1), pp. 6. Date of Electronic Publication: 2024 Jan 06.
Typ publikacji:
Letter
MeSH Terms:
Drug Users*
Substance Abuse, Intravenous*/complications
Substance Abuse, Intravenous*/epidemiology
Substance Abuse, Intravenous*/therapy
Epidemics*
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Humans ; Mozambique
Opinia redakcyjna
Tytuł:
Willingness to use and distribute HIV self-testing kits among people who inject drugs in the San Diego-Tijuana border region.
Autorzy:
Pines HA; Division of Epidemiology and Biostatistics, School of Public Health, San Diego State University, San Diego, CA, USA. .; Herbert Wertheim School of Public Health and Human Longevity Science, University of California, San Diego, La Jolla, CA, USA. .; Department of Medicine, University of California, San Diego, La Jolla, CA, USA. .
Eger WH; Department of Medicine, University of California, San Diego, La Jolla, CA, USA.; School of Social Work, San Diego State University, San Diego, CA, USA.
Skaathun B; Department of Medicine, University of California, San Diego, La Jolla, CA, USA.
Vera CF; Department of Medicine, University of California, San Diego, La Jolla, CA, USA.
Harvey-Vera A; Department of Medicine, University of California, San Diego, La Jolla, CA, USA.
Rangel G; Mexico Section of the US-Mexico Border Health Commission, Tijuana, Baja California, Mexico.; El Colegio de la Frontera Norte, Tijuana, Baja California, Mexico.
Strathdee SA; Department of Medicine, University of California, San Diego, La Jolla, CA, USA.
Bazzi AR; Herbert Wertheim School of Public Health and Human Longevity Science, University of California, San Diego, La Jolla, CA, USA.; School of Public Health, Boston University, Boston, MA, USA.
Pokaż więcej
Źródło:
Harm reduction journal [Harm Reduct J] 2024 Jan 03; Vol. 21 (1), pp. 4. Date of Electronic Publication: 2024 Jan 03.
Typ publikacji:
Journal Article
MeSH Terms:
Substance Abuse, Intravenous*/epidemiology
HIV Infections*/diagnosis
HIV Infections*/epidemiology
Drug Users*
Humans ; Self-Testing ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł:
WaSH insecurity and anxiety among people who inject drugs in the Tijuana-San Diego border region.
Autorzy:
Avelar Portillo LJ; Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla, CA, USA. .; Benioff Homelessness and Housing Initiative, School of Medicine, University of California San Francisco, San Francisco, CA, USA. .
Calderón-Villarreal A; Department of Family and Preventive Medicine, University of California, San Diego, La Jolla, CA, USA.; School of Public Health, San Diego State University, San Diego, CA, USA.
Abramovitz D; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, CA, USA.
Harvey-Vera A; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, CA, USA.; Facultad de Medicina, Campus Tijuana, Universidad de Xochicalco, Tijuana, Baja California, México.; United States-Mexico Border Health Commission, Tijuana, Baja California, Mexico.
Cassels S; Department of Geography, University of California Santa Barbara, Santa Barbara, CA, USA.
Vera CF; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, CA, USA.
Munoz S; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, CA, USA.
Tornez A; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, CA, USA.
Rangel G; United States-Mexico Border Health Commission, Tijuana, Baja California, Mexico.; Departamento de Estudios de Población, Colegio de La Frontera Norte, Tijuana, México.
Strathdee SA; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, CA, USA.
Kayser GL; Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla, CA, USA.
Pokaż więcej
Źródło:
BMC public health [BMC Public Health] 2024 Jan 02; Vol. 24 (1), pp. 19. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:
Substance Abuse, Intravenous*/epidemiology
Substance Abuse, Intravenous*/complications
Drug Users*
Drinking Water*
Humans ; Male ; Female ; Sanitation ; Cross-Sectional Studies ; Anxiety/epidemiology ; Anxiety Disorders/complications ; Hygiene
Czasopismo naukowe
Tytuł:
Models of good practice to enhance infectious disease care cascades among people who inject drugs: a qualitative study of interventions implemented in European settings.
Autorzy:
Horváth I; Austrian National Public Health Institute (Gesundheit Österreich GmbH, GOEG), Vienna, Austria. .
Mårdh O; European Centre for Disease Prevention and Control (ECDC), Solna, Sweden.
Schwarz T; Austrian National Public Health Institute (Gesundheit Österreich GmbH, GOEG), Vienna, Austria.
Pokaż więcej
Źródło:
BMC health services research [BMC Health Serv Res] 2023 Dec 04; Vol. 23 (1), pp. 1352. Date of Electronic Publication: 2023 Dec 04.
Typ publikacji:
Journal Article
MeSH Terms:
Substance Abuse, Intravenous*/complications
Substance Abuse, Intravenous*/epidemiology
Acquired Immunodeficiency Syndrome*
Drug Users*
Communicable Diseases*
Tuberculosis*/drug therapy
Tuberculosis*/epidemiology
Tuberculosis*/prevention & control
Hepatitis C*/epidemiology
Hepatitis C*/prevention & control
Humans
Czasopismo naukowe
Tytuł:
Injection cessation and relapse to injection and the associated factors among people who inject drugs in Iran: The Rostam study.
Autorzy:
Mehmandoost S; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Mirzazadeh A; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA.
Karamouzian M; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.; Centre on Drug Policy Evaluation, MAP Centre for Urban Health Solutions, St. Michael's Hospital, Toronto, ON, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
Khezri M; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.; Department of Epidemiology, New York University School of Global Public Health, New York, NY, USA.
Sharafi H; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.; Research Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, QC, Canada.; Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, Montréal, QC, Canada.
Shahesmaeili A; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Maghsoudi SH; Modeling in Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Ghalekhani N; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Tavakoli F; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Bazrafshani MS; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Shokoohi M; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Aghaali N; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Haghdoost AA; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Sharifi H; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran. .
Pokaż więcej
Źródło:
Substance abuse treatment, prevention, and policy [Subst Abuse Treat Prev Policy] 2023 Nov 29; Vol. 18 (1), pp. 72. Date of Electronic Publication: 2023 Nov 29.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*/complications
Substance Abuse, Intravenous*/epidemiology
Substance Abuse, Intravenous*/complications
Drug Users*
Hepatitis C*/epidemiology
Hepatitis C*/complications
Humans ; Female ; Iran/epidemiology ; Cohort Studies ; Hepacivirus ; Recurrence ; Prevalence
Czasopismo naukowe
Tytuł:
Effects of a social network intervention on HIV seroconversion among people who inject drugs in Ukraine: moderation by network gender composition.
Autorzy:
Wiginton JM; Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, San Diego, USA.; School of Social Work, San Diego State University, 5500 Campanile Dr, San Diego, CA, 92182, USA.
Booth R; Department of Psychiatry, University of Colorado School of Medicine, Denver, USA.
Smith LR; Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, San Diego, USA.
Shakya S; Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, San Diego, USA.
da Silva CE; Herbert Wertheim School of Public Health & Human Longevity Science, University of California San Diego, San Diego, USA.; School of Public Health, San Diego State University, San Diego, USA.
Patterson TL; Departments of Psychiatry, University of California San Diego, San Diego, USA.
Pitpitan EV; Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, San Diego, USA. .; School of Social Work, San Diego State University, 5500 Campanile Dr, San Diego, CA, 92182, USA. .
Pokaż więcej
Źródło:
Harm reduction journal [Harm Reduct J] 2023 Nov 08; Vol. 20 (1), pp. 165. Date of Electronic Publication: 2023 Nov 08.
Typ publikacji:
Randomized Controlled Trial; Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
HIV Seropositivity*/complications
HIV Infections*/epidemiology
HIV Infections*/prevention & control
HIV Infections*/complications
Drug Users*
Substance Abuse, Intravenous*/epidemiology
Substance Abuse, Intravenous*/complications
Male ; Humans ; Female ; Ukraine/epidemiology ; Social Networking
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies